No Detail Found!

Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.

Author(s)
Summayya Shawana Department of Pathology, Bahria University Medical and Dental College, Karachi, Pakistan
Shahnaz Imdad Kehar Department of Pathology, Basic Medical Sciences Institute, JPMC, Karachi, Pakistan
Saleha Masood Department of Pathology, Jinnah Medical and Dental College, Karachi, Pakistan
Iram Aamir Department of Physiology, Jinnah Medical and Dental College, Karachi, Pakistan
Abstract
Objective: To determine the expression of cyclin D1 and PTEN (phosphatase and tensin homolog) in endometrial hyperplasias and neoplasias. Study Design: Analytical study. Place and Duration of Study: The study was conducted at BMSI, JPMC, Karachi, from January 2008 to December 2012. Methodology: Analysis of endometrial samples, comprising of hysterectomies and curettage, was carried out. Immunohistochemical staining was done for PTEN and cyclin D1 expression. Results: Fifty-three endometrial samples including 23 endometrial carcinomas, 6 complex hyperplasias with atypia, 14 complex hyperplasias without atypia, 6 simple hyperplasias without atypia and 4 normal proliferative endometrium were analyzed. Fifty-two percent (12 out of 23) and 48% (11 out of 23) cases of endometrial carcinomas showed complete loss of PTEN expression and cyclin D1 over expression, respectively. Five (5 out of 6) cases of complex hyperplasias with atypia and 64.28% (9 out of 14) cases of complex hyperplasia without atypia showed complete loss of or diminished expression of PTEN whereas 66.66% (4 out of 6) cases of endometrial hyperplasia with atypia and 50% (7 out of 14) cases of endometrial hyperplasia without atypia showed cyclin D1 overexpression (p < 0.001). Conclusion: Loss of PTEN, expression and cyclin D1 overexpression was seen in a significant number of well differentiated endometrial adenocarcinomas and complex hyperplasias with atypia, suggesting both as an early event in endometrial carcinogenesis.
Publication Details
Page(s) 277-282
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 4, Year: 2016

Request the full text from PASTIC

References
JemalA,BrayF,CenterMM,FerlayJ,WardE,FormanD, 2011.,CA Cancer J Clin 61 69 -90
p6.,Collective cancer registry report (1994-2011). Shaukat Khanum Cancer Hospital and Research Centre -
TrimbleCL,MethodM,LeitaoM,LoffeO,HamptonM, 2012.Management of endometrial pre-cancers,Obstet Gynecol 120 1160 -75
SilverbergSG,MutterGL,KurmanRJ,Kubik-HuckRA,NogalesF,TavassoliFA,StrattonMR, 2003.Tumors of the uterine corpus: epithelial tumors and related lesions, in WHO classification of tumors: pathology and genetics of tumors of the breast and female genital organs,Tavassoli FA 221 -32
MutterGL, 2000.Endometrial intraepithelial neoplasia (EIN): Will it bring order to the chaos? The endometrial collaborative group,Gynecol Oncol 76 287 -90
MonteNM,WebsterKA,NeubergD,DresslerGR,MutterGL, 2010.Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer,Cancer Res 70 6225 -32
QuddusMR,OlogunBA,SungCJ,SteinhoffMM,LawrenceWD, 2009.Utility of PTEN expression of endometrial surface epithelial changes and underlying atypical endometrial hyperplasia,Int J Gynecol Pathol 28 471 -6
KalaM,GillM,GuptaV,SrivastavaD,TanwarP,GoayalV, 2012.Cyclin D1 expression in hyperplasia and carcinoma of the endometrium and its correlation with histologic grade and tumor type,J Gynecol Surg 30 1 -4
WuW,SlomovitzBM,SolimanPT,SchmelerKM,CelestinoJ,MilamMR, 2006.Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma,Int J Gynecol Cancer 16 1668 -72
AhmedZ,AzadNS,YaqoobN,HusainA,AhsanA,KhanAN, 2007.Frequency of primary solid malignant neoplasms in both sexes as seen in our practice,J Ayub Med Coll Abbottabad 19 53 -5
AbdEl-Maqsoud,NM , El-Gelany S., 2009.Differential expression patterns of PTEN in cyclic, hyperplastic and malignant endometrium: its relation with ER, PR, and clinicopathological parameters,J Egypt Natl Canc Inst 21 323 -31
LeeH,ChoiHJ,KangCS,LeeHJ,LeeWS,ParkCS, 2012.Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma,Mod Pathol 25 1508 -15
RobbeEJ,van KuijkSM,de BoedEM,SmitsLJ,van der WurffAA,KruitwagenRF, 2012.Predicting the coexistence of an endometrial adenocarcinoma in the presence of atypical complex hyperplasia: immunohistochemical analysis of endometrial samples,Int J Gynecol Cancer 22 1264 -72
StewartCJR,CrookML,LeungYC,PlattenM., 2009.Expression of cell cycle regulatory proteins in endometrial adenocarcinoma; variations in conventional tumor areas and in microcytic, elongated and fragmented glands,Mod Pathol 22 725 -33
LiangS,MuK,WangY,ZhouZ,ZhangJ,ShengY, 2013.Cyclin D1, a prominent prognostic marker for endometrial diseases,Diagn Pathol 15 8 -138
KuhnE,WuRC,WuG,GuanB,ZhangJ,WangY, 2012.Identification of molecular pathway aberrations in uterine serous carcinoma by genome wide analysis,J Natl Cancer Inst 19 1503 -13
DjordjevicB,HennessyBT,LiJ,BarkohBA,LuthraR,GordonB., 2012.Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry out-performs gene sequencing,Mod Pathol 25 699 -708
BalanR,AmalineC,CraucuxE,CaruntaID,GheorghitaV,TomaO, 2008.Expression of cyclin D1 and Ki-67 in endometrial hyperplasia and carcinomas,Sectonea Genetica Si Biologie Moleculara 9 17 -23
TanbirojnP,TriratanachatS,TrivijitsilpP,NiruthisardS., 2008.Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma,J Med Assoc Thai 91 1161 -4
ShervaCR,GhoshA,KumarM. Cyclin, 2014.D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium,JPGM 61 15 -20
MutterGL,LinMC,FitzgeraldJT,KumJB, 2000.EngCharis. Changes in endometrial PTEN expression throughout the human menstrual cycle,J Clin Endocrinol Metab 85 2334 -88
0

Citations

0

Downloads

74

Views